Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > PRME Prime Medicine > Detailed Quotes

PRME Prime Medicine

Watchlist
16.500
-0.690-4.01%
Close 12/01 16:00 ET
High
17.550
Open
17.360
Turnover
1.99M
Low
16.463
Pre Close
17.190
Volume
118.74K
Market Cap
1.60B
P/E(TTM)
Loss
52wk High
21.730
Shares
97.21M
P/E(Static)
Loss
52wk Low
14.520
Float Cap
169.85M
Bid/Ask %
0.00%
Historical High
21.730
Shs Float
10.29M
Volume Ratio
0.47
Historical Low
14.520
Dividend TTM
--
Div Yield TTM
--
P/B
-7.19
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.15%
Amplitude
6.33%
Avg Price
16.748
Lot Size
1
Float Cap
169.85M
Bid/Ask %
0.00%
Historical High
21.730
Shs Float
10.29M
Volume Ratio
0.47
Historical Low
14.520
Dividend TTM
--
P/B
-7.19
Dividend LFY
--
Turnover Ratio
1.15%
Amplitude
6.33%
Avg Price
16.748
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Prime Medicine, Inc. operates as a biotechnology company. It develops one-time curative genetic therapies, Prime Editors to address the wide spectrum of diseases by deploying its Prime Editing technology. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.
CEO: Dr. Keith Gottesdiener, M.D.
Market: NASDAQ
Listing Date: 10/20/2022
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist